Publications by authors named "P Bernasconi"

Claim this Profile
P
Progressive Multifocal Leukoencephalopathy (PML) after hematopoietic cell transplantation (HCT): a retrospective study of Infectious Diseases Working Party (IDWP) of the EBMT.
Jarosław Dybko, Wojciech Szlasa, Lidia Gil, Lotus Wendel, Gloria Tridello, Paolo Bernasconi

Bone Marrow Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial.
Anna Maria Raiola, Benedetto Bruno, Antonio Maria Risitano, Federico Mosna, Irene Maria Cavattoni, Paolo Bernasconi

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-specific anti-HLA antibodies (DSAs) in patients undergoing allogeneic hematopoietic stem cell transplantation from mismatched donors on behalf of GITMO and AIBT.
Ursula La Rocca, Roberto Ricci, Alfonso Piciocchi, Walter Barberi, Elena Oldani, Paolo Bernasconi

Blood Transfus· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation.
Chiara Nozzoli, Martina Pucillo, Luisa Giaccone, Alessandro Rambaldi, Maria Teresa Lupo Stanghellini, Paolo Bernasconi

Transplant Cell Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.
Gianluca Cavallaro, Anna Grassi, Chiara Pavoni, Maria Caterina Micò, Alessandro Busca, Paolo Bernasconi

Blood Cancer J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis